Assistant Professor of Medicine, Channing Laboratory
Pulmonology
Dr. Dawn L. Demeo, MD
|
|
Give Review
Dawn Demeo practices Pulmonology. She researched medicine at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University has a rank of 18 in research and a 49 in primary care Dawn L. Demeo, MD is a published doctor and has 84 publications published. The lastest was: 'Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity.' She is registered with Medicare.
Publications
- Reduced Bone Density and Vertebral Fractures in Smokers: Men and COPD Patients at Increased Risk.
- Effect of culture conditions on microRNA expression in primary adult control and COPD lung fibroblasts in vitro.
- Smoking Associated Site Specific Differential Methylation in Buccal Mucosa in the COPDGene Study.
- Fetal Lung and placental methylation is associated with in utero nicotine exposure.
- Menthol cigarette smoking in the COPDGene cohort: Relationship with COPD, comorbidities and CT metrics.
- A Novel Method for Detecting Association Between DNA Methylation and Diseases Using Spatial Information.
- Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene.
- Risk loci for Chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.
- Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema.
- DNA methylation and ancestry. The smoke starts to clear.
- Interstitial pneumonitis and the risk of Chronic allograft rejection in lung transplant recipients.
- Integration of Mouse and Human Genome-Wide Association Data Identifies KCNIP4 as an Asthma Gene.
- Racial Differences in CT Phenotypes in COPD.
- Alu and LINE-1 methylation and Lung function in the normative ageing study.
- Systemic Steroid Exposure is Associated with Differential Methylation in Chronic Obstructive Pulmonary Disease.
- Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome.
- Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency.
- Variable DNA Methylation is Associated with COPD and Lung Function.
- Gene-environment interaction testing in family-based association studies with phenotypically ascertained samples: a causal inference approach.
- Arriving Now at the Crossroads of Technology: Sex and Gender Differences in COPD.
- Association of SERPINE2 with Asthma.
- Combining Disease Models to Test for Gene-Environment Interaction in Nuclear Families.
- Polymorphisms in surfactant protein-D are associated with Chronic obstructive pulmonary disease.
- Genome-Wide Association Analysis of Body Mass in Chronic Obstructive Pulmonary Disease.
- Multistudy fine mapping of chromosome 2q identifies XRCC5 as a Chronic obstructive pulmonary disease susceptibility gene.
- Variants in FAM13A are associated with Chronic obstructive pulmonary disease.
- MMP12, lung function, and COPD in high-risk populations.
- Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene.
- Molecular biomarkers for quantitative and discrete COPD phenotypes.
- Testing and estimating gene-environment interactions in family-based association studies.
- National Emphysema Treatment Trial state of the art: genetics of Emphysema.
- IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
- The Yin and Yang of COPD: sex/gender differences in the National Emphysema Treatment Trial.
- Genetic determinants of Emphysema distribution in the national Emphysema treatment trial.
- Polymorphisms in IL13, total IgE, eosinophilia, and Asthma exacerbations in childhood.
- Genetic linkage and association analysis of COPD-related traits on chromosome 8p.
- Microarray data-based prioritization of Chronic obstructive pulmonary disease susceptibility genes.
- Genetic determinants of functional impairment in Chronic obstructive pulmonary disease.
- Genetic association analysis of functional impairment in Chronic obstructive pulmonary disease.
- Concordance of genotypes in pre- and post-Lung transplantation DNA samples.
- Attempted replication of reported Chronic obstructive pulmonary disease candidate gene associations.
- Genomic screening and replication using the same data set in family-based association testing.
- Genome-wide linkage of forced mid-expiratory flow in Chronic obstructive pulmonary disease.
- Smoke and mirrors: Mouse models as a reflection of human Chronic obstructive pulmonary disease.
- Predictors of survival in severe, early onset COPD.
- Ambient air pollution and oxygen saturation.
- A family-based association test for repeatedly measured quantitative traits adjusting for unknown environmental and/or polygenic effects.
- Genetics of Chronic obstructive pulmonary disease.
- Power and design considerations for a general class of family-based association tests: quantitative traits.
- A Simplified Score to Quantify Comorbidity in COPD.
- Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.
- Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of Emphysema risk.
- PBAT: tools for family-based association studies.
- A new powerful non-parametric two-stage approach for testing multiple phenotypes in family-based association studies.
- Using the noninformative families in family-based association tests: a powerful new testing strategy.
- COPD: problems in diagnosis and measurement.
- Transmission of lymphocytic choriomeningitis virus by organ transplantation.
- Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program.
- Clinical status of Lung transplantation.
- Lung transplantation at the turn of the century.
- Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity.
- Expression and regulation of Ly-6 differentiation antigens by murine osteoblasts.
- The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD).
- The SERPINE2 gene is associated with Chronic obstructive pulmonary disease.
- Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.
- Xenobiotic metabolizing enzyme gene polymorphisms predict response to Lung volume reduction surgery.
- Clinical determinants of exacerbations in severe, early-onset COPD.
- Polymorphic variation in surfactant protein B is associated with COPD exacerbations.
- Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency.
- Associations of IL6 polymorphisms with lung function decline and COPD.
- Genetic association analysis of COPD candidate genes with bronchodilator responsiveness.
- Heritability of Lung function in severe alpha-1 antitrypsin deficiency.
- Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD.
- Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD.
- Gender differences in COPD: are women more susceptible to smoking effects than men?
- Parsing the effects of individual SNPs in candidate genes with family data.
- Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies.
- Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD).
- Racial differences in quality of life in patients with COPD.
- Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study.
- Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report.
- A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.
- Peripheral blood gene expression profiles in COPD subjects.
Schools
Joan Sanford I Weill Medical College Of Cornell University
Brigham and Women39s Hospital
Conditions Treated
- Asthma
- Bronchiectasis
- Bronchitis
- COPD (Chronic Obstructive Pulmonary Disease)
- View All
Doctors Specialties
- Pulmonology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Brigham and Women's Hospital -
Weill Cornell Medical College of Cornell University
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1346206588 | |
| NPPES Provider LastName | DEMEO | |
| NPPES Provider FirstName | DAWN | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 54.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346206588 |
| Last Name Of The Provider | DEMEO |
| First Name Of The Provider | DAWN |
| View All |
Similar Doctors
|
|
Dr. Barry S. Shea, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barrett T. Kitch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger K. Morgan, MD |
|
|
Dr. Angela J. Frank, MD |
|
|
Dr. Augustine M. Choi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry Koziel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marilyn P. Griffin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter D. Goldbach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adnan Majid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy K. Chi, MD
This Doctor is OpenDoctor Recommended.
|